全文获取类型
收费全文 | 116102篇 |
免费 | 12636篇 |
国内免费 | 7663篇 |
专业分类
耳鼻咽喉 | 1066篇 |
儿科学 | 1539篇 |
妇产科学 | 842篇 |
基础医学 | 9236篇 |
口腔科学 | 2673篇 |
临床医学 | 14147篇 |
内科学 | 11744篇 |
皮肤病学 | 1259篇 |
神经病学 | 3635篇 |
特种医学 | 4697篇 |
外国民族医学 | 28篇 |
外科学 | 11455篇 |
综合类 | 28952篇 |
现状与发展 | 35篇 |
一般理论 | 6篇 |
预防医学 | 11854篇 |
眼科学 | 2145篇 |
药学 | 13407篇 |
192篇 | |
中国医学 | 10636篇 |
肿瘤学 | 6853篇 |
出版年
2024年 | 602篇 |
2023年 | 1789篇 |
2022年 | 4621篇 |
2021年 | 5807篇 |
2020年 | 4934篇 |
2019年 | 3172篇 |
2018年 | 3274篇 |
2017年 | 3876篇 |
2016年 | 3197篇 |
2015年 | 5264篇 |
2014年 | 6686篇 |
2013年 | 7476篇 |
2012年 | 10986篇 |
2011年 | 11484篇 |
2010年 | 9503篇 |
2009年 | 7981篇 |
2008年 | 8691篇 |
2007年 | 7984篇 |
2006年 | 7069篇 |
2005年 | 5666篇 |
2004年 | 3867篇 |
2003年 | 3120篇 |
2002年 | 2419篇 |
2001年 | 2125篇 |
2000年 | 1729篇 |
1999年 | 905篇 |
1998年 | 364篇 |
1997年 | 330篇 |
1996年 | 284篇 |
1995年 | 247篇 |
1994年 | 188篇 |
1993年 | 131篇 |
1992年 | 117篇 |
1991年 | 93篇 |
1990年 | 94篇 |
1989年 | 72篇 |
1988年 | 58篇 |
1987年 | 54篇 |
1986年 | 41篇 |
1985年 | 31篇 |
1984年 | 13篇 |
1983年 | 8篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1926年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
6.
Lei Yang You-Ling Shi Yan Ma Wei-Wei Ren Guang-Ming Pang Jiao Liu 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2022,130(1):43-52
Krüppel-like factor 16 (KLF16), a member of the Krüppel-like factor (KLF) family, has been extensively investigated in multiple cancer types. However, the role of KLF16 in oral squamous cell carcinoma (OSCC) remains unknown. Thus, we conducted this study to investigate its related mechanism. KLF16 expression in OSCC cell lines was quantified by western blotting. Then, OECM1 and OC3 cells were divided into Blank, siCtrl, siKLF16#1 and siKLF16#2 groups. Subsequently, cell proliferation was detected using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assays, cell migration and invasion were detected with wound healing and Transwell assays, and cell cycle distribution and cell apoptosis were detected via flow cytometry. KLF16, p21, CDK4, Cyclin D1 and p-Rb expression was detected by western blotting. Finally, xenograft models were established in nude mice to observe the in vivo effects of KLF16 on OSCC. KLF16 protein expression was upregulated in OSCC cells. Compared to the cells in the Blank group, the OECM1 and OC3 cells in the siKLF16#1 group and siKLF16#2 group exhibited a sharp decrease in proliferation but a remarkable increase in apoptosis. Moreover, the proportion of cells in the G0/G1 phase notably increased and that in the S phase decreased, with evident decreases in cell invasion and migration. Moreover, KLF16, cyclin-dependent kinase 4 (CDK4), Cyclin D1 and p-Rb protein expression was upregulated, but p21 expression was downregulated. The mice in the siKLF16#1 and siKLF16#2 xenograft model groups exhibited slower tumour growth and smaller tumours with evident downregulation of Ki67 expression compared to the mice in the Blank group. KLF16 expression was upregulated in OSCC cells, and interfering with KLF16 led to cell cycle arrest, inhibited OSCC cell growth and promoted cell apoptosis. 相似文献
7.
目的 系统评价中药治疗哮喘-慢阻肺(ACO)的疗效与安全性。方法 全面检索PubMed、Cochrane Library、Web of Science、中国知网、万方、维普、中国医学文献数据库,纳入有关中医药治疗ACO的随机对照试验(RCT),运用Cochrane手册对纳入研究的方法学质量进行评估,采用Review Manager 5.3进行Meta分析。结果 共纳入32项RCT,包括2688例ACO患者,其中试验组1361例,对照组1327例。Meta分析结果显示,中医药可以显著改善ACO患者的中医证候疗效[RR=1.19,95% CI(1.13,1.25),P<0.00001]、CAT评分[MD=-3.62,95% CI(-4.37,-2.87),P<0.00001]、ACT评分[MD=3.42,95% CI(2.23,4.62),P<0.00001],、中医证候总积分[MD=-3.61,95% CI(-4.83,-2.39),P<0.00001]、FEV1[MD=0.59,95% CI(0.08,1.10),P=0.02]、FEV1%[MD=8.61,95% CI(5.20,12.1),P<0.00001]、FEV1/FVC[MD=6.52,95% CI(4.24,8.80),P<0.00001]、6 min步行实验[MD=41.18,95% CI(22.15,60.21),P<0.0001]、急性发作次数[MD=-2.46,95% CI(-3.62,-1.13),P<0.0001]。所有研究均未报道严重不良反应。结论 中药治疗ACO,可以显著提高临床疗效,改善患者的肺功能且具有较好安全性,但是需要更高质量、多样本、多中心的随机对照试验进一步确认。 相似文献
8.
9.
10.